Announcements under Regulation 30(LODR)-Newspaper Publication
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Ltd has informed BSE that it published its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 in the Financial Express (English, all-India edition) and Deepika (Malayalam, Cochin edition) on November 15, 2025, as required under SEBI LODR Regulations. The Board had approved these results at its meeting held on November 14, 2025. Based on the results published, standalone Q2 FY26 revenue from operations stood at around ₹18.79 Cr versus ₹20.43 Cr in Q2 FY25, a modest decline of about 8% year-on-year. The company reported a Q2 FY26 standalone net loss of roughly ₹2.78 Cr, marginally better than the ₹3.01 Cr loss in the year-ago quarter. For H1 FY26, the loss narrowed to approximately ₹5.68 Cr from ₹7.08 Cr in H1 FY25, even as half-yearly revenue edged up to ₹25.81 Cr from ₹23.56 Cr.
This is essentially a procedural compliance filing under SEBI's newspaper publication rule and is not new financial news on its own. The underlying results indicate Kerala Ayurveda remains in quarterly losses, although losses are narrowing both sequentially and on a year-on-year basis, and H1 revenue has grown modestly — a mildly improving trend but no near-term profitability signal yet.